DOSSIER · 13F Holders · Q2 2026
AIXC
QUALIGEN THERAPEUTICS INC
15 institutions still hold QUALIGEN THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 74754R301·15 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
15 institutions reported AIXC in Q2 2026. VANGUARD CAPITAL MANAGEMENT LLC leads at 43.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.